GE HealthCare Technologies Inc

We’re trimming a 2025 top gainer, taking profits on the market’s rotation into health stocks
We are selling 75 shares of GE Healthcare at roughly $90 each. Following Monday’s trade, Jim Cramer’s Charitable Trust will own 900 shares of GEHC, decreasing its weighting to about 2.25% from 2.42%. We’re taking advantage of the market’s rotation into health-care stocks by locking in profits in GE Healthcare. Following an up-and-down 2024, GE […]
Read More
Our 5 top-performing portfolio stocks since December’s Monthly Meeting are tech free
It’s been a topsy-turvy start to 2025 for the stock market. Since the Club’s December Monthly Meeting, Wall Street has been barraged by headlines that sent equities seesawing down and then up. The S & P 500 wrapped up 2024 with a roughly 23% gain despite tumbling in the final four sessions of the year and […]
Read More
Stocks pop on cool inflation, hot bank earnings — plus, new rules on biotech exports to China
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Markets: Wall Street surged Wednesday thanks to the second encouraging inflation report this week and a batch of strong bank earnings. The consumer price index, excluding […]
Read More
AWS and General Catalyst partner to speed up development of health-care AI tools
Attendees walk through an expo hall at AWS re:Invent, a conference hosted by Amazon Web Services, at the Venetian in Las Vegas on Nov. 28, 2023. Noah Berger | Getty Images Entertainment | Getty Images Amazon Web Services and venture capital firm General Catalyst on Monday announced a new multi-year partnership in their latest push […]
Read More
Bargain hunting: These 8 portfolio stocks look quite cheap, but only some are worth buying
The holiday shopping season has come and gone. When it comes to stock picking, at least, the desire to find a bargain is as strong as ever. A recent analysis of our portfolio revealed we own more than a couple cheap stocks, including one of our newer additions in Bristol Myers Squibb . Still, we’re […]
Read More
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Wall Street is chewing over critical […]
Read More
Stocks making the biggest moves midday: AbbVie, Tesla, Cigna, Morgan Stanley and more
Check out the companies making headlines in midday trading. Tesla — The electric vehicle stock popped 7% to build on last week’s 29% gain as investors bet that a Trump administration would fare well for the company and CEO Elon Musk. AbbVie — Shares tumbled 12% after the pharmaceutical company said its experimental schizophrenia drug […]
Read More
We’re hiking our GEHC price target, looking beyond a mixed quarter to next year’s catalysts
GE Healthcare reported a mixed quarter before Wednesday’s opening bell. While revenue slightly missed, an earnings beat along with a number of other positives pushed the stock higher. Revenue rose just under 1% year over year to $4.86 billion in the third quarter, just short the $4.87 billion expected, according to analyst estimates compiled by […]
Read More